To include your compound in the COVID-19 Resource Center, submit it here.

Infectious disease

INDICATION: HIV / AIDS

Cell culture studies identified a Prezista darunavir-based HIV protease inhibitor that could help treat protease inhibitor-resistant

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE